September 4, 2024

Supplementary Figure S7 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Supplementary Figure S7 shows the analysis from the multispectral immunohistochemistry of ex vivo tumors treated with single agents and in combination.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Nguyen et al. (Wed,) studied this question.

synapsesocial.com/papers/68e59691b6db643587531456 https://doi.org/https://doi.org/10.1158/1535-7163.26935046

Preguntar a la IA

Me gusta

Guardar